Source: BMC Blog

BMC Blog Genomic insights into Schistosoma mansoni TRPM channel: Assessing potential drug resistance in endemic populations

Recent research highlights the value of genomic surveillance in tracking the potential emergence of praziquantel resistance in schistosomes, and provides a resource for guiding future treatment strategies in schistosomiasis-endemic regions.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Rachel Burley's photo - Managing Director of BMC

Managing Director

Rachel Burley

CEO Approval Rating

74/100

Read more